Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919425 · ClinicalTrials.gov registry record
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
A clinical trial of Leukemia and Myelodysplastic Syndromes, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 1,294
- Enrollment target
- 20
- Study locations
NCT00919425: Completed study of Leukemia and Myelodysplastic Syndromes, sponsored by SWOG Cancer Research Network.
NCT00919425 is a study of Leukemia and Myelodysplastic Syndromes that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 1,294 participants, above the 481-participant average among 233 other Leukemia trials with a reported enrollment target (169% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919425, a study of Leukemia and Myelodysplastic Syndromes, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 1,294 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment. PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with hematologic cancer to be tested in the laboratory.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
California
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center - Burbank
- Peninsula Medical Center - Burlingame
- North Bay Cancer Center - Fairfield
- Sutter Health - Western Division Cancer Research Group - Novato
- University of California Davis Cancer Center - Sacramento
- California Pacific Medical Center - California Campus - San Francisco
- Stanford Cancer Center - Stanford
- Sutter Solano Medical Center - Vallejo
Colorado
- University of Colorado Cancer Center at UC Health Sciences Center - Aurora
- Memorial Hospital Cancer Center - Colorado Springs - Colorado Springs
- Veterans Affairs Medical Center - Denver - Denver
- Poudre Valley Hospital - Fort Collins
- Front Range Cancer Specialists - Fort Collins
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center - Grand Junction
Georgia
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital - Albany
- Piedmont Hospital - Atlanta
Arkansas
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
Connecticut
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford
Florida
- M.D. Anderson Cancer Center at Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,294 participants |
| Start Date | 1999-04 |
| Est. Completion | 2012-01 |
What the finished NCT00919425 record still lists
NCT00919425 is an observational study that tracks outcomes without assigning an intervention. Its 1,294 participants enrollment target places it among the larger protocols in the corpus, above the 481-participant average among 233 other Leukemia trials with a reported enrollment target (169% higher).
The record links to 3 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT00919425 names 20 study sites across 6 states, led by California, Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT00919425 about?
NCT00919425 is a clinical study titled "S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer". RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment. PURPOSE: The purpose of this study is to collect and store blood and bone marr...
What is the current status of trial NCT00919425?
This trial is currently completed. The enrollment target is 1,294 participants. The study started on 1999-04. Estimated completion is 2012-01.
What conditions does trial NCT00919425 study?
This clinical trial studies the following conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms.
What interventions are being tested in trial NCT00919425?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT00919425?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00919425 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00919425's enrollment target sits among peer trials
1,294 9th of 233 higher than 225 of 233 other Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia